Clinical trial
Prospective, Observational, Longitudinal Study in Paediatric Patients With AD, Treated With Dupilumab in Spain
NCT06415175 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Observational, Longitudinal Study in Paediatric Patients With AD, Treated With Dupilumab in Spain
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 14, 2024
- Completion date
- November 23, 2027
- Enrollment
- 143 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis